Sugi Predict

Sugi Predict / Compounds / SCHEMBL884654

SCHEMBL884654

SCHEMBL884654

Cn1cc(S(=O)(=O)N2CCCC(n3c(-c4ccccc4)c(C(=O)N4CCNCC4)n(Cc4cccc(Oc5ccccc5)c4)c3=O)C2)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ BCL9 O00512 2/20 0.34
▸ CTNNB1 P35222 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CHRM3 P20309 1/20 0.34
▸ HTR1A P08908 1/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ HDAC1 Q13547 2/20 0.33
▸ HDAC8 Q9BY41 2/20 0.33
▸ HDAC6 Q9UBN7 2/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ CCR8 P51685 1/20 0.33
▸ BTK Q06187 1/20 0.33
▸ AXL P30530 1/20 0.33
▸ MERTK Q12866 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2062324 0.95 ALDH1A1 (0.38) POLBKDM4EALDH1A1LMNAKMT2A
SCHEMBL2062532 0.94 HTR1A (0.38) BCL9CTNNB1ALDH1A1LMNASMN1; SMN2
SCHEMBL884801 0.92 HTR1A (0.37) BCL9CTNNB1ALDH1A1LMNAHTR1A
SCHEMBL884750 0.92 KDM4E (0.38) POLBKDM4EBCL9CTNNB1ALDH1A1
SCHEMBL885861 0.91 SMN1; SMN2 (0.37) KDM4EALDH1A1LMNASMN1; SMN2HTR1A
SCHEMBL885934 0.91 HTR1A (0.35) BCL9CTNNB1ALDH1A1LMNASMN1; SMN2
SCHEMBL885904 0.91 HTR1A (0.36) BCL9CTNNB1ALDH1A1LMNAHTR1A
SCHEMBL885566 0.91 HTR1A (0.36) KDM4EBCL9CTNNB1ALDH1A1LMNA
SCHEMBL884720 0.90 HTR1A (0.34) BCL9CTNNB1LMNAHTR1AHTR7
SCHEMBL885437 0.90 ROCK2 (0.36) KDM4EALDH1A1LMNASMN1; SMN2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148367-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-03 — — US claimed
US-20100105665-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-29 — — US claimed
WO-2008089005-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 — — WO claimed
US-8148367-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-03 — — US disclosed
US-8148367-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-03 — — US disclosed
US-8148367-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-03 — — US disclosed
US-20100105665-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-29 — — US disclosed
US-20100105665-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-29 — — US disclosed
US-20100105665-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-29 — — US disclosed
WO-2008089005-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 — — WO disclosed
WO-2008089005-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105665-A1 RENIN INHIBITORS REN, ACE, AGT POLB 1491/4885KDM4E 2733/4885BCL9 4776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.